Royal Bank of Canada
RNTX

Royal Bank of Canada’s Rein Therapeutics RNTX Stock Holding History

Royal Bank of Canada’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57,257
Closed -$101K – 7459
2025
Q1 		$101K Sell
57,257
-49,715
-46% -$104K ﹤0.01% 5213
2024
Q4 		$246K Buy
106,972
+98,972
+1,237% +$300K ﹤0.01% 4647
2024
Q3 		$28K Sell
8,000
-52,241
-87% -$140K ﹤0.01% 5985
2024
Q2 		$167K Buy
60,241
+24,241
+67% +$99.6K ﹤0.01% 4903
2024
Q1 		$239K Buy
+36,000
New +$172K ﹤0.01% 4542
2023
Q2 		– Sell
-25
Closed – – 7744
2023
Q1 		$0 Buy
25
+23
+1,150% +$49 ﹤0.01% 7586
2022
Q4 		$0 Buy
+2
New +$7 ﹤0.01% 7825
2020
Q3 		– Sell
-31
Closed -$1K – 6990
2020
Q2 		$1K Hold
31
– – ﹤0.01% 6500
2020
Q1 		$0 Buy
+31
New +$373 ﹤0.01% 7101
2019
Q4 		– Sell
-32
Closed – – 7190
2019
Q3 		$0 Buy
32
+31
+3,100% +$429 ﹤0.01% 7217
2019
Q2 		$0 Hold
1
– – ﹤0.01% 7263
2019
Q1 		$0 Hold
1
– – ﹤0.01% 7169
2018
Q4 		$0 Hold
1
– – ﹤0.01% 7185
2018
Q3 		$0 Buy
+1
New +$67 ﹤0.01% 6996
2018
Q2 		– Hold
0
– – – 6823
2018
Q1 		– Hold
0
– – – 6871
2017
Q4 		– Sell
-22
Closed -$6K – 6959
2017
Q3 		$6K Buy
+22
New +$5.52K ﹤0.01% 6403

Other funds holding RNTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

Royal Bank of Canada's RNTX Position: Q2 2025 in Review

Royal Bank of Canada sold out of Rein Therapeutics (RNTX) in Q2 2025, closing a stake of 57,257 shares — an estimated $101K sold.

Royal Bank of Canada first reported a position in RNTX in Q3 2017 and held it in 15 quarters. The position peaked at $246K in Q4 2024. 36 funds tracked by Wall St. Rank hold RNTX as of Q2 2025.

  • Royal Bank of Canada reported no remaining Rein Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 57,257 Rein Therapeutics shares in Q2 2025, an estimated $101K.
  • Royal Bank of Canada first reported a position in Rein Therapeutics in Q3 2017 and held it in 15 quarters.
  • Royal Bank of Canada's Rein Therapeutics position peaked at $246K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2025.

Based on Royal Bank of Canada's 13F filing for Q2 2025, filed 14 Aug 2025.